ADRIENNE HARRIS: Open Payments
NPI 1083318687 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 76 payments from 23 companies in 2025. Trend: 2023 $874 · 2024 $2,051 · 2025 $1,596
Food & beverage: $1,554Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $332 |
| Dexcom, Inc. | 6 | $228 |
| Amgen Inc. | 5 | $110 |
| Lilly USA, LLC | 6 | $90 |
| BETA BIONICS, INC. | 6 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $88 |
| Corcept Therapeutics | 3 | $67 |
| Alexion Pharmaceuticals, Inc. | 2 | $65 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
Products named: Ozempic, Dexcom G6 Transmitter, MOUNJARO, iLet Bionic Pancreas, Korlym, TEPEZZA, STRENSIQ, ISTURISA.
Industry payments across LA — which companies pay providers there.
